| ACC | American College of Cardiology |
| AECs | Airway epithelial cells |
| AHA | American Heart Association |
| AH | Arterial hypertension |
| AHI | Apnea-hypopnea index |
| ALEs | Advanced lipoxidation end-products |
| AMPK | AMP-activated protein kinase |
| AOR | Adjusted odds ratio |
| ARIC | Atherosclerosis Risk in Communities Study |
| BMI | Body mass index |
| BNP | B-type natriuretic peptide |
| BP | Blood pressure |
| CAD | Coronary artery disease |
| CD68 | Cluster of differentiation 68 |
| CHF | Chronic heart failure |
| CI | Confidence interval |
| CKD | Chronic kidney disease |
| COPD | Chronic obstructive pulmonary disease |
| CPAP | Continuous positive airway pressure |
| CR | Cardiac rehabilitation |
| CSE | Cigarette smoke extract |
| CVD | Cardiovascular disease |
| CVH | Cardiovascular health |
| DAMP | Damage-associated molecular pattern |
| DCM | Diabetic cardiomyopathy |
| DEX | Dexpanthenol |
| ECHO | Echocardiographic |
| ECM | Extracellular matrix |
| ECV | Extracellular volume |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| eNOS | Endothelial nitric oxide synthase |
| EPCs | Endothelial progenitor cells |
| ERC | Elastin receptor complex |
| ESC | European Society of Cardiology |
| FAK kinases | Focal adhesion kinase kinases |
| FBG | Fasting blood glucose |
| FDA | Food and Drug Administration |
| FHS | Framingham Heart Study |
| Gal-3 | Galectin-3 |
| GSH-Px | Glutathione peroxidase |
| HbA1C | Hemoglobin A1c (glycated hemoglobin) |
| HCD | Hypercaloric diet |
| HF | Heart failure |
| HFD | High-fat diet |
| HFpEF | Heart failure with preserved ejection fraction |
| HFSA | Heart Failure Society of America |
| HIIT | High-intensity interval training |
| HOMA-IR | Homeostasis Model Assessment of Insulin Resistance |
| HR | Hazard ratio |
| hsCRP | High-sensitivity C-reactive protein |
| HUVECs | Human umbilical vein endothelial cells |
| HVS | Hepatic vein serum |
| ICAM-1 | Intercellular adhesion molecule-1 |
| IF | Intermittent fasting |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| LCN2 | Lipocalin-2 |
| LE8 | Life’s Essential 8 |
| LGALS3BP | Galectin-3 binding protein |
| LLPS | Liquid–liquid phase separation |
| LPC | Lysophosphatidylcholine |
| LPS | Lipopolysaccharide |
| LS7 | Life’s Simple 7 |
| LV | Left ventricle |
| LVEF | Left ventricular ejection fraction |
| LVH | Left ventricular hypertrophy |
| MCP | Modified citrus pectin |
| MDA | Malondialdehyde |
| MIACT | Moderate-intensity aerobic continuous training |
| MRI | Magnetic resonance imaging |
| MUC1-C/EGFR | Mucin 1 C-terminal subunit/Epidermal Growth Factor Receptor |
| NAC | N-acetylcysteine |
| NADPH oxidase 2 | Nicotinamide adenine dinucleotide phosphate oxidase 2 |
| NASH | Nonalcoholic steatohepatitis |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | Nitric oxide |
| NWGR | Asparagine-Tryptophan-Glycine-Arginine |
| NT-proBNP | N-terminal pro–B-type natriuretic peptide |
| OGTT | Oral glucose tolerance test |
| OR | Odds ratio |
| OSA | Obstructive sleep apnea |
| oxLDL | Oxidized low-density lipoprotein |
| PI3K | Phosphoinositide 3-kinase |
| POEM | Prospective Investigation of Obesity, Energy and Metabolism |
| PREVEND | Prevention of Renal and Vascular End-stage Disease |
| PUFA | Polyunsaturated fatty acids |
| PVS | Portal vein serum |
| Ref. | References |
| ROS | Reactive oxygen species |
| RUNX-2 | Runt-related transcription factor 2 |
| RV | Right ventricular |
| RVEF | Right ventricular ejection fraction |
| SANRA | Scale for the Assessment of Narrative Review Articles |
| SAT | Subcutaneous adipose tissue |
| SBP | Systolic blood pressure |
| SGLT2i | Sodium-glucose co-transporter 2 inhibitors |
| SIRT1 | Sirtuin 1 |
| SOD | Superoxide dismutase |
| SNP | Sodium nitroprusside |
| SPPB | Short physical performance battery |
| SR proteins | Serine/arginine-rich proteins |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| STEMI | ST-elevation myocardial infarction |
| SVS | Systemic venous serum |
| T2DM | Type 2 diabetes mellitus |
| TC | Total cholesterol |
| TG | Triglycerides |
| TGF-β | Transforming growth factor beta. |
| TLR4 | Toll-like receptor 4 |
| TNF-α | Tumor necrosis factor alpha |
| TOS | Total oxidative status |
| VAT | Visceral adipose tissue |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VCID | Vascular cognitive impairment and dementia |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| VO2 | Oxygen uptake |
| VSMCs | Vascular smooth muscle cells |
| WAT | White adipose tissue |
| WC | Waist circumference |
| WONDERFUL | Weekly ONe-Day WatER-only Fasting InterventionaL trial |
| WT | Wild type |
| YAP | Yes-associated protein |
| α9nAChR | α9 nicotinic acetylcholine receptor |
| ↑ | Increase |
| ↓ | Decrease |